These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 3864858

  • 1. Cyclosporine blocks the induction of class I and class II MHC products in mouse kidney by graft-vs-host disease.
    Autenried P, Halloran PF.
    J Immunol; 1985 Dec; 135(6):3922-8. PubMed ID: 3864858
    [Abstract] [Full Text] [Related]

  • 2. Systemic immunologic stimuli increase class I and II antigen expression in mouse kidney.
    Halloran PF, Jephthah-Ochola J, Urmson J, Farkas S.
    J Immunol; 1985 Aug; 135(2):1053-60. PubMed ID: 3891851
    [Abstract] [Full Text] [Related]

  • 3. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM, Katz SI.
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [Abstract] [Full Text] [Related]

  • 4. Changes in Ia expression in mouse kidney during acute graft-vs-host disease.
    Wadgymar A, Urmson J, Baumal R, Halloran PF.
    J Immunol; 1984 Apr; 132(4):1826-32. PubMed ID: 6366052
    [Abstract] [Full Text] [Related]

  • 5. Regulation of MHC expression in vivo. Bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell-independent, cyclosporine-sensitive mechanism.
    Jephthah-Ochola J, Urmson J, Farkas S, Halloran PF.
    J Immunol; 1988 Aug 01; 141(3):792-800. PubMed ID: 3135312
    [Abstract] [Full Text] [Related]

  • 6. Increased class I and class II MHC products and mRNA in kidneys of MRL-lpr/lpr mice during autoimmune nephritis and inhibition by cyclosporine.
    Halloran PF, Urmson J, Ramassar V, Laskin C, Autenried P.
    J Immunol; 1988 Oct 01; 141(7):2303-12. PubMed ID: 3049805
    [Abstract] [Full Text] [Related]

  • 7. Effects of cyclosporine on systemic MHC expression. Evidence that non-T cells produce interferon-gamma in vivo and are inhibitable by cyclosporine.
    Halloran PF, Urmson J, Farkas S, Phillips RA, Fulop G, Cockfield S, Autenried P.
    Transplantation; 1988 Aug 01; 46(2 Suppl):68S-72S. PubMed ID: 3136568
    [Abstract] [Full Text] [Related]

  • 8. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Aug 01; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 9. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R, Sprent J.
    J Immunol; 1985 Nov 01; 135(5):3004-10. PubMed ID: 3876371
    [Abstract] [Full Text] [Related]

  • 10. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR, Lipsky PE, Thiele DL.
    J Immunol; 1995 Aug 15; 155(4):1784-95. PubMed ID: 7636234
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
    Brok HP, Vossen JM, Heidt PJ.
    Bone Marrow Transplant; 1997 Mar 15; 19(6):601-6. PubMed ID: 9085739
    [Abstract] [Full Text] [Related]

  • 12. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
    Leibnitz RR, Lipsky PE, Thiele DL.
    J Immunol; 1994 Dec 01; 153(11):4959-68. PubMed ID: 7963559
    [Abstract] [Full Text] [Related]

  • 13. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y, Guo K, Chen Y, Song Z, Li J, Deng L.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug 01; 23(8):411-4. PubMed ID: 12411044
    [Abstract] [Full Text] [Related]

  • 14. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L, Guiffre A, Atkinson K, Rainer SP, Sewell WA.
    Bone Marrow Transplant; 2002 Jan 01; 29(2):151-8. PubMed ID: 11850710
    [Abstract] [Full Text] [Related]

  • 15. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T, Eto M, Lin T, Nishimura Y, Kong YY, Nomoto K, Nomoto K.
    J Immunol; 1994 Nov 01; 153(9):4311-20. PubMed ID: 7930630
    [Abstract] [Full Text] [Related]

  • 16. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells.
    Callahan GN.
    J Immunol; 1984 May 01; 132(5):2649-57. PubMed ID: 6201554
    [Abstract] [Full Text] [Related]

  • 17. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR, Majewski D, Ozker K, Hanson G.
    J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263
    [Abstract] [Full Text] [Related]

  • 18. Maturation of bone marrow lymphocytes. IV. Kinetics of maturation and renewal of lymphocytes expressing Ia and H-2K antigens.
    Rahal MD, Osmond DG.
    Immunology; 1981 Nov 01; 44(3):463-72. PubMed ID: 6947963
    [Abstract] [Full Text] [Related]

  • 19. The regulation of expression of MHC products in mice. Factors determining the level of expression in kidneys of normal mice.
    Cockfield SM, Urmson J, Pleasants JR, Halloran PF.
    J Immunol; 1990 Apr 15; 144(8):2967-74. PubMed ID: 1691224
    [Abstract] [Full Text] [Related]

  • 20. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T, Hamano T, Saheki K, Kuroiwa T, Kataoka Y, Takemoto Y, Ogata A, Sugihara A, Terada N, Fujimoto J, Kakishita E.
    Cell Immunol; 1999 Oct 10; 197(1):30-8. PubMed ID: 10555993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.